Global Peptide-based Drug Market Size, Status and Forecast 2021-2027

Global Peptide-based Drug Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide-based Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Oral
1.2.4 Other
1.3 Market by Application
1.3.1 Global Peptide-based Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Peptide-based Drug Market Perspective (2016-2027)
2.2 Peptide-based Drug Growth Trends by Regions
2.2.1 Peptide-based Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Peptide-based Drug Historic Market Share by Regions (2016-2021)
2.2.3 Peptide-based Drug Forecasted Market Size by Regions (2022-2027)
2.3 Peptide-based Drug Industry Dynamic
2.3.1 Peptide-based Drug Market Trends
2.3.2 Peptide-based Drug Market Drivers
2.3.3 Peptide-based Drug Market Challenges
2.3.4 Peptide-based Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide-based Drug Players by Revenue
3.1.1 Global Top Peptide-based Drug Players by Revenue (2016-2021)
3.1.2 Global Peptide-based Drug Revenue Market Share by Players (2016-2021)
3.2 Global Peptide-based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Peptide-based Drug Revenue
3.4 Global Peptide-based Drug Market Concentration Ratio
3.4.1 Global Peptide-based Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide-based Drug Revenue in 2020
3.5 Peptide-based Drug Key Players Head office and Area Served
3.6 Key Players Peptide-based Drug Product Solution and Service
3.7 Date of Enter into Peptide-based Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide-based Drug Breakdown Data by Type
4.1 Global Peptide-based Drug Historic Market Size by Type (2016-2021)
4.2 Global Peptide-based Drug Forecasted Market Size by Type (2022-2027)
5 Peptide-based Drug Breakdown Data by Application
5.1 Global Peptide-based Drug Historic Market Size by Application (2016-2021)
5.2 Global Peptide-based Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Peptide-based Drug Market Size (2016-2027)
6.2 North America Peptide-based Drug Market Size by Type
6.2.1 North America Peptide-based Drug Market Size by Type (2016-2021)
6.2.2 North America Peptide-based Drug Market Size by Type (2022-2027)
6.2.3 North America Peptide-based Drug Market Size by Type (2016-2027)
6.3 North America Peptide-based Drug Market Size by Application
6.3.1 North America Peptide-based Drug Market Size by Application (2016-2021)
6.3.2 North America Peptide-based Drug Market Size by Application (2022-2027)
6.3.3 North America Peptide-based Drug Market Size by Application (2016-2027)
6.4 North America Peptide-based Drug Market Size by Country
6.4.1 North America Peptide-based Drug Market Size by Country (2016-2021)
6.4.2 North America Peptide-based Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Peptide-based Drug Market Size (2016-2027)
7.2 Europe Peptide-based Drug Market Size by Type
7.2.1 Europe Peptide-based Drug Market Size by Type (2016-2021)
7.2.2 Europe Peptide-based Drug Market Size by Type (2022-2027)
7.2.3 Europe Peptide-based Drug Market Size by Type (2016-2027)
7.3 Europe Peptide-based Drug Market Size by Application
7.3.1 Europe Peptide-based Drug Market Size by Application (2016-2021)
7.3.2 Europe Peptide-based Drug Market Size by Application (2022-2027)
7.3.3 Europe Peptide-based Drug Market Size by Application (2016-2027)
7.4 Europe Peptide-based Drug Market Size by Country
7.4.1 Europe Peptide-based Drug Market Size by Country (2016-2021)
7.4.2 Europe Peptide-based Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Peptide-based Drug Market Size (2016-2027)
8.2 Asia-Pacific Peptide-based Drug Market Size by Type
8.2.1 Asia-Pacific Peptide-based Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Peptide-based Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Peptide-based Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Peptide-based Drug Market Size by Application
8.3.1 Asia-Pacific Peptide-based Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Peptide-based Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Peptide-based Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Peptide-based Drug Market Size by Region
8.4.1 Asia-Pacific Peptide-based Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Peptide-based Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Peptide-based Drug Market Size (2016-2027)
9.2 Latin America Peptide-based Drug Market Size by Type
9.2.1 Latin America Peptide-based Drug Market Size by Type (2016-2021)
9.2.2 Latin America Peptide-based Drug Market Size by Type (2022-2027)
9.2.3 Latin America Peptide-based Drug Market Size by Type (2016-2027)
9.3 Latin America Peptide-based Drug Market Size by Application
9.3.1 Latin America Peptide-based Drug Market Size by Application (2016-2021)
9.3.2 Latin America Peptide-based Drug Market Size by Application (2022-2027)
9.3.3 Latin America Peptide-based Drug Market Size by Application (2016-2027)
9.4 Latin America Peptide-based Drug Market Size by Country
9.4.1 Latin America Peptide-based Drug Market Size by Country (2016-2021)
9.4.2 Latin America Peptide-based Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide-based Drug Market Size (2016-2027)
10.2 Middle East & Africa Peptide-based Drug Market Size by Type
10.2.1 Middle East & Africa Peptide-based Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Peptide-based Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Peptide-based Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Peptide-based Drug Market Size by Application
10.3.1 Middle East & Africa Peptide-based Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Peptide-based Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Peptide-based Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Peptide-based Drug Market Size by Country
10.4.1 Middle East & Africa Peptide-based Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Peptide-based Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Peptide-based Drug Introduction
11.1.4 Sanofi Revenue in Peptide-based Drug Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Peptide-based Drug Introduction
11.2.4 Teva Revenue in Peptide-based Drug Business (2016-2021)
11.2.5 Teva Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Peptide-based Drug Introduction
11.3.4 Novo Nordisk Revenue in Peptide-based Drug Business (2016-2021)
11.3.5 Novo Nordisk Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Peptide-based Drug Introduction
11.4.4 Takeda Revenue in Peptide-based Drug Business (2016-2021)
11.4.5 Takeda Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Peptide-based Drug Introduction
11.5.4 Eli Lilly Revenue in Peptide-based Drug Business (2016-2021)
11.5.5 Eli Lilly Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Peptide-based Drug Introduction
11.6.4 AstraZeneca Revenue in Peptide-based Drug Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Peptide-based Drug Introduction
11.7.4 Novartis Revenue in Peptide-based Drug Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Peptide-based Drug Introduction
11.8.4 AbbVie Revenue in Peptide-based Drug Business (2016-2021)
11.8.5 AbbVie Recent Development
11.9 Ipsen
11.9.1 Ipsen Company Details
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Peptide-based Drug Introduction
11.9.4 Ipsen Revenue in Peptide-based Drug Business (2016-2021)
11.9.5 Ipsen Recent Development
11.10 Ferring
11.10.1 Ferring Company Details
11.10.2 Ferring Business Overview
11.10.3 Ferring Peptide-based Drug Introduction
11.10.4 Ferring Revenue in Peptide-based Drug Business (2016-2021)
11.10.5 Ferring Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Peptide-based Drug Introduction
11.11.4 Merck Revenue in Peptide-based Drug Business (2016-2021)
11.11.5 Merck Recent Development
11.12 The Medicines
11.12.1 The Medicines Company Details
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Peptide-based Drug Introduction
11.12.4 The Medicines Revenue in Peptide-based Drug Business (2016-2021)
11.12.5 The Medicines Recent Development
11.13 J & J
11.13.1 J & J Company Details
11.13.2 J & J Business Overview
11.13.3 J & J Peptide-based Drug Introduction
11.13.4 J & J Revenue in Peptide-based Drug Business (2016-2021)
11.13.5 J & J Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Peptide-based Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Oral
Table 4. Key Players of Other
Table 5. Global Peptide-based Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Peptide-based Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Peptide-based Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Peptide-based Drug Market Share by Regions (2016-2021)
Table 9. Global Peptide-based Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Peptide-based Drug Market Share by Regions (2022-2027)
Table 11. Peptide-based Drug Market Trends
Table 12. Peptide-based Drug Market Drivers
Table 13. Peptide-based Drug Market Challenges
Table 14. Peptide-based Drug Market Restraints
Table 15. Global Peptide-based Drug Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Peptide-based Drug Market Share by Players (2016-2021)
Table 17. Global Top Peptide-based Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide-based Drug as of 2020)
Table 18. Ranking of Global Top Peptide-based Drug Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Peptide-based Drug Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Peptide-based Drug Product Solution and Service
Table 22. Date of Enter into Peptide-based Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peptide-based Drug Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Peptide-based Drug Revenue Market Share by Type (2016-2021)
Table 26. Global Peptide-based Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Peptide-based Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Peptide-based Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Peptide-based Drug Revenue Market Share by Application (2016-2021)
Table 30. Global Peptide-based Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Peptide-based Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Peptide-based Drug Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Peptide-based Drug Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Peptide-based Drug Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Peptide-based Drug Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Peptide-based Drug Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Peptide-based Drug Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Peptide-based Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Peptide-based Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Peptide-based Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Peptide-based Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Peptide-based Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Peptide-based Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Peptide-based Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Peptide-based Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Peptide-based Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Peptide-based Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Peptide-based Drug Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Peptide-based Drug Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Peptide-based Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Peptide-based Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Peptide-based Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Peptide-based Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Peptide-based Drug Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Peptide-based Drug Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Peptide-based Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Peptide-based Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Peptide-based Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Peptide-based Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Peptide-based Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Peptide-based Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. Sanofi Company Details
Table 63. Sanofi Business Overview
Table 64. Sanofi Peptide-based Drug Product
Table 65. Sanofi Revenue in Peptide-based Drug Business (2016-2021) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. Teva Company Details
Table 68. Teva Business Overview
Table 69. Teva Peptide-based Drug Product
Table 70. Teva Revenue in Peptide-based Drug Business (2016-2021) & (US$ Million)
Table 71. Teva Recent Development
Table 72. Novo Nordisk Company Details
Table 73. Novo Nordisk Business Overview
Table 74. Novo Nordisk Peptide-based Drug Product
Table 75. Novo Nordisk Revenue in Peptide-based Drug Business (2016-2021) & (US$ Million)
Table 76. Novo Nordisk Recent Development
Table 77. Takeda Company Details
Table 78. Takeda Business Overview
Table 79. Takeda Peptide-based Drug Product
Table 80. Takeda Revenue in Peptide-based Drug Business (2016-2021) & (US$ Million)
Table 81. Takeda Recent Development
Table 82. Eli Lilly Company Details
Table 83. Eli Lilly Business Overview
Table 84. Eli Lilly Peptide-based Drug Product
Table 85. Eli Lilly Revenue in Peptide-based Drug Business (2016-2021) & (US$ Million)
Table 86. Eli Lilly Recent Development
Table 87. AstraZeneca Company Details
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Peptide-based Drug Product
Table 90. AstraZeneca Revenue in Peptide-based Drug Business (2016-2021) & (US$ Million)
Table 91. AstraZeneca Recent Development
Table 92. Novartis Company Details
Table 93. Novartis Business Overview
Table 94. Novartis Peptide-based Drug Product
Table 95. Novartis Revenue in Peptide-based Drug Business (2016-2021) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. AbbVie Company Details
Table 98. AbbVie Business Overview
Table 99. AbbVie Revenue in Peptide-based Drug Business (2016-2021) & (US$ Million)
Table 100. AbbVie Recent Development
Table 101. Ipsen Company Details
Table 102. Ipsen Business Overview
Table 103. Ipsen Peptide-based Drug Product
Table 104. Ipsen Revenue in Peptide-based Drug Business (2016-2021) & (US$ Million)
Table 105. Ipsen Recent Development
Table 106. Ferring Company Details
Table 107. Ferring Business Overview
Table 108. Ferring Peptide-based Drug Product
Table 109. Ferring Revenue in Peptide-based Drug Business (2016-2021) & (US$ Million)
Table 110. Ferring Recent Development
Table 111. Merck Company Details
Table 112. Merck Business Overview
Table 113. Merck Peptide-based Drug Product
Table 114. Merck Revenue in Peptide-based Drug Business (2016-2021) & (US$ Million)
Table 115. Merck Recent Development
Table 116. The Medicines Company Details
Table 117. The Medicines Business Overview
Table 118. The Medicines Peptide-based Drug Product
Table 119. The Medicines Revenue in Peptide-based Drug Business (2016-2021) & (US$ Million)
Table 120. The Medicines Recent Development
Table 121. J & J Company Details
Table 122. J & J Business Overview
Table 123. J & J Peptide-based Drug Product
Table 124. J & J Revenue in Peptide-based Drug Business (2016-2021) & (US$ Million)
Table 125. J & J Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide-based Drug Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Oral Features
Figure 4. Other Features
Figure 5. Global Peptide-based Drug Market Share by Application: 2020 VS 2027
Figure 6. Cancer Case Studies
Figure 7. Metabolic Disorders Case Studies
Figure 8. Central Nervous System Case Studies
Figure 9. Other Case Studies
Figure 10. Peptide-based Drug Report Years Considered
Figure 11. Global Peptide-based Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Peptide-based Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Peptide-based Drug Market Share by Regions: 2020 VS 2027
Figure 14. Global Peptide-based Drug Market Share by Regions (2022-2027)
Figure 15. Global Peptide-based Drug Market Share by Players in 2020
Figure 16. Global Top Peptide-based Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide-based Drug as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Peptide-based Drug Revenue in 2020
Figure 18. Global Peptide-based Drug Revenue Market Share by Type (2016-2021)
Figure 19. Global Peptide-based Drug Revenue Market Share by Type (2022-2027)
Figure 20. North America Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Peptide-based Drug Market Share by Type (2016-2027)
Figure 22. North America Peptide-based Drug Market Share by Application (2016-2027)
Figure 23. North America Peptide-based Drug Market Share by Country (2016-2027)
Figure 24. United States Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Peptide-based Drug Market Share by Type (2016-2027)
Figure 28. Europe Peptide-based Drug Market Share by Application (2016-2027)
Figure 29. Europe Peptide-based Drug Market Share by Country (2016-2027)
Figure 30. Germany Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Peptide-based Drug Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Peptide-based Drug Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Peptide-based Drug Market Share by Region (2016-2027)
Figure 40. China Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Peptide-based Drug Market Share by Type (2016-2027)
Figure 48. Latin America Peptide-based Drug Market Share by Application (2016-2027)
Figure 49. Latin America Peptide-based Drug Market Share by Country (2016-2027)
Figure 50. Mexico Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Peptide-based Drug Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Peptide-based Drug Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Peptide-based Drug Market Share by Country (2016-2027)
Figure 56. Turkey Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Peptide-based Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Sanofi Revenue Growth Rate in Peptide-based Drug Business (2016-2021)
Figure 60. Teva Revenue Growth Rate in Peptide-based Drug Business (2016-2021)
Figure 61. Novo Nordisk Revenue Growth Rate in Peptide-based Drug Business (2016-2021)
Figure 62. Takeda Revenue Growth Rate in Peptide-based Drug Business (2016-2021)
Figure 63. Eli Lilly Revenue Growth Rate in Peptide-based Drug Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Peptide-based Drug Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Peptide-based Drug Business (2016-2021)
Figure 66. AbbVie Revenue Growth Rate in Peptide-based Drug Business (2016-2021)
Figure 67. Ipsen Revenue Growth Rate in Peptide-based Drug Business (2016-2021)
Figure 68. Ferring Revenue Growth Rate in Peptide-based Drug Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Peptide-based Drug Business (2016-2021)
Figure 70. The Medicines Revenue Growth Rate in Peptide-based Drug Business (2016-2021)
Figure 71. J & J Revenue Growth Rate in Peptide-based Drug Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs